Story thread · 4 reports / 4 sources
Amgen gains on late-stage trial win for Sjögren's disease therapy
seekingalpha.com · 4h · first report
The coverage
- Amgen's Phase 3 Sjögren's win; Novartis' $900m radioligand deal
endpts.com · 2h
- Amgen Drug May Offer Sjögren’s Patients First Effective Therapy
bloomberg.com · 3h
- Amgen Boasts Success In Sjogren's; Shares Charge Ahead
investors.com · 4h
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.